share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4:持股变动声明-董事 Borgeson Blake
美股sec公告 ·  06/13 17:40
Moomoo AI 已提取核心信息
Blake Borgeson, a reporting person associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock on June 11, 2024. The shares were sold at a price of $8.4531 per share, resulting in a total transaction value of approximately $96,762.64. Following the transaction, Borgeson directly holds a total of 7,188,563 shares in the company. The sale was conducted in the open market.
Blake Borgeson, a reporting person associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock on June 11, 2024. The shares were sold at a price of $8.4531 per share, resulting in a total transaction value of approximately $96,762.64. Following the transaction, Borgeson directly holds a total of 7,188,563 shares in the company. The sale was conducted in the open market.
与Recursion Pharmaceuticals, Inc. [RXRX]相关的报告人Blake Borgeson于2024年6月11日完成了销售11,447股A类普通股的交易。这些股票以8.4531美元的价格出售,交易总价值约为96,762.64美元。交易后,Borgeson直接持有该公司的7,188,563股股份。此次交易是在公开市场上进行的。
与Recursion Pharmaceuticals, Inc. [RXRX]相关的报告人Blake Borgeson于2024年6月11日完成了销售11,447股A类普通股的交易。这些股票以8.4531美元的价格出售,交易总价值约为96,762.64美元。交易后,Borgeson直接持有该公司的7,188,563股股份。此次交易是在公开市场上进行的。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息